Siemens Healthineers is investing $150 million in new projects to expand production, create jobs and better serve customers in the United States, our largest market globally.
The new investments come on top of the $900 million Siemens Healthineers spends on R&D in the U.S. annually and more than $1 billion invested through facilities expansion, acquisitions and strategic partnerships in the U.S. since 2019.
The latest investments include the following:
- Bringing manufacturing back to the U.S.: relocation of manufacturing operations for Varian, a Siemens Healthineers company, from Baja, Mexico to Palo Alto, CA, adding approximately 50 new manufacturing jobs. The change will reduce the complexity of our global supply chain and improve our ability to respond to demand for Varian鈥檚 radiotherapy solutions.
- Strengthening supply-chain resilience: opening mega supply depots in Dayton, NJ and Manteca, CA to increase availability of parts by nearly a third and offer unprecedented delivery flexibility to customers.
- Helping healthcare providers digitize and transform care delivery: construction of a 60,000 square foot Siemens Healthineers Experience Center in Charlotte, NC. The center is part of The Pearl, Charlotte鈥檚 research and innovation district.
"North Carolina is home to some of the leading research and innovation firms in the nation,鈥 said North Carolina Governor Josh Stein. 鈥淪iemens Healthineers鈥 $141 million investment in the Pearl in Charlotte is the latest in a long line of companies that see the value of our well-trained workforce thanks to advanced health education programs in our state.鈥
Added John Kowal, president and head of Siemens Healthineers in the Americas: 鈥淥ur significant U.S. employee base and broad portfolio of innovations are making vital contributions to the American healthcare system. With these new investments we鈥檙e further demonstrating our long-term commitment and desire to grow along with the American economy.鈥
Other facts about Siemens Healthineers in the U.S.:
- Employs 17,000 people in 18 locations nationwide
- Generates 36% of global revenue
- Global headquarters for Laboratory Diagnostics, Varian, Ultrasound, Molecular Imaging, and PET businesses
- Portfolio includes in vitro and in vivo (imaging) diagnostics, image guided therapy, comprehensive cancer care, digital and AI-driven solutions, technology, workforce and operations consulting
- Strategic partner to many of the nation鈥檚 leading healthcare providers
Media contact
Julie Gibson
Email: julie.gibson@siemens-healthineers.com
Phone: 917.929.5779
Visit the Siemens Healthineers Press Center.
聽Subscribe to our .
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around 鈧22.4 billion. Further information is available at .
